Cargando…
Knockdown of NF-κB1 by shRNA Inhibits the Growth of Renal Cell Carcinoma In Vitro and In Vivo
Renal cell carcinoma (RCC) accounts for approximately 2%–3% of human malignancies and is the most aggressive among urologic tumors. Biological heterogeneity, drug resistance, and chemotherapy side effects are the biggest obstacles to the effective treatment of RCC. The NF-κB transcription factor is...
Autores principales: | Ikegami, Amanda, Teixeira, Luiz Felipe S., Braga, Marina S., Dias, Matheus Henrique Dos S., Lopes, Eduardo C., Bellini, Maria Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844753/ https://www.ncbi.nlm.nih.gov/pubmed/29212573 http://dx.doi.org/10.3727/096504017X15120379906339 |
Ejemplares similares
-
Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012) -
Criteria for effective design, construction, and gene knockdown by shRNA vectors
por: Taxman, Debra J, et al.
Publicado: (2006) -
Single copy shRNA configuration for ubiquitous gene knockdown in mice
por: Seibler, Jost, et al.
Publicado: (2005) -
Reversible gene knockdown in mice using a tight, inducible shRNA expression system
por: Seibler, Jost, et al.
Publicado: (2007) -
Inducible Transgenic Rat Model for Diabetes Mellitus Based on shRNA-Mediated Gene Knockdown
por: Kotnik, Katarina, et al.
Publicado: (2009)